Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system agents. Its structure supports enhanced metabolic stability and improved blood-brain barrier penetration in drug candidates. Also employed in the preparation of bioactive molecules where the combination of an amino group and fluorine atom allows for targeted modifications in medicinal chemistry. Commonly utilized in research settings for designing enzyme inhibitors and receptor ligands.